INSR and Hyperglycemia: Liver is a relevant organ to assess the impact of insulin and glucagon deficiency because re-expression of the glucagon receptor in the liver of STZ-treated Gcgr-/- mice, and conditional inactivation of the insulin receptor in hepatocytes are both sufficient to trigger hyperglycemia (Lee et al., 2012; Michael et al., 2000).